Get the Stockscreener App
12.56
2.84%
-0.3274
Integra Lifesciences Holdings Corp stock is traded at $12.56, with a volume of 341.34K.
It is down -2.84% in the last 24 hours and down -34.74% over the past month.
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.
See More
Previous Close:
$12.89
Open:
$12.89
24h Volume:
341.34K
Relative Volume:
0.40
Market Cap:
$1.28B
Revenue:
$1.53B
Net Income/Loss:
$40.23M
P/E Ratio:
25.13
EPS:
0.5
Net Cash Flow:
$60.93M
1W Performance:
-25.68%
1M Performance:
-34.74%
6M Performance:
-49.46%
1Y Performance:
-50.50%
1-Day Range:
$12.40
$12.89
1-Week Range:
$11.60
$14.79
52-Week Range:
$11.60
$32.66
Integra Lifesciences Holdings Corp Stock (IART) Company Profile
Name
Integra Lifesciences Holdings Corp
Sector
Industry
Phone
(609) 275-0500
Address
1100 CAMPUS ROAD, PRINCETON, NJ
Compare IART with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IART
Integra Lifesciences Holdings Corp
|
12.56 | 1.28B | 1.53B | 40.23M | 60.93M | 0.50 |
|
ABT
Abbott Laboratories
|
134.69 | 227.71B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
103.18 | 152.66B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
382.58 | 142.93B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
84.17 | 107.17B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
74.03 | 44.04B | 5.54B | 4.18B | 623.10M | 7.00 |
Integra Lifesciences Holdings Corp Stock (IART) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-31-25 | Upgrade | Argus | Hold → Buy |
| Dec-02-24 | Initiated | Morgan Stanley | Underweight |
| Oct-07-24 | Upgrade | BTIG Research | Sell → Neutral |
| Jul-30-24 | Downgrade | BTIG Research | Neutral → Sell |
| Jul-30-24 | Downgrade | Citigroup | Neutral → Sell |
| May-07-24 | Downgrade | Oppenheimer | Outperform → Perform |
| May-07-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-03-24 | Upgrade | Citigroup | Sell → Neutral |
| Dec-05-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Nov-14-23 | Initiated | CL King | Buy |
| Aug-24-23 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Jul-12-23 | Upgrade | Jefferies | Hold → Buy |
| Jun-08-23 | Downgrade | Argus | Buy → Hold |
| May-24-23 | Downgrade | JP Morgan | Neutral → Underweight |
| May-23-23 | Downgrade | Citigroup | Neutral → Sell |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Jul-25-22 | Initiated | Morgan Stanley | Equal-Weight |
| Apr-13-22 | Downgrade | Truist | Buy → Hold |
| Dec-17-21 | Upgrade | JP Morgan | Underweight → Neutral |
| Sep-15-21 | Downgrade | BTIG Research | Buy → Neutral |
| Oct-08-20 | Downgrade | JP Morgan | Neutral → Underweight |
| May-27-20 | Initiated | Citigroup | Neutral |
| Apr-03-20 | Initiated | SunTrust | Buy |
| Jan-07-20 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Jan-07-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jan-03-19 | Initiated | SunTrust | Buy |
| Nov-28-18 | Initiated | UBS | Neutral |
| Aug-07-18 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jul-26-18 | Upgrade | BTIG Research | Neutral → Buy |
| Jul-02-18 | Downgrade | Citigroup | Buy → Neutral |
| Jan-05-18 | Resumed | Cantor Fitzgerald | Neutral |
| Jan-02-18 | Downgrade | BofA/Merrill | Buy → Neutral |
| Nov-09-17 | Reiterated | RBC Capital Mkts | Sector Perform |
| Oct-30-17 | Downgrade | Wells Fargo | Outperform → Market Perform |
| Oct-27-17 | Downgrade | JP Morgan | Overweight → Neutral |
| Jun-30-17 | Initiated | Cantor Fitzgerald | Overweight |
| May-02-17 | Reiterated | RBC Capital Mkts | Sector Perform |
| Jan-13-17 | Reiterated | RBC Capital Mkts | Sector Perform |
| Jan-06-17 | Upgrade | JMP Securities | Mkt Perform → Mkt Outperform |
| Dec-12-16 | Initiated | UBS | Buy |
View All
Integra Lifesciences Holdings Corp Stock (IART) Latest News
Integra Lifesciences (IART): Analyst Lowers Price Target to $25 | IART Stock News - GuruFocus
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cable One, Inc. - GlobeNewswire Inc.
Integra LifeSciences stock target cut to $25 by JMP - Investing.com
Integra LifeSciences (IART) Sees Lowered Price Target Amid Market Reaction | IART Stock News - GuruFocus
JPMorgan Chase & Co. Issues Pessimistic Forecast for Integra LifeSciences (NASDAQ:IART) Stock Price - Defense World
Wells Fargo & Company Issues Pessimistic Forecast for Integra LifeSciences (NASDAQ:IART) Stock Price - Defense World
U.S. Regenerative Artificial Skin Market 2025-2032: Top Trends - openPR.com
Integra LifeSciences (NASDAQ:IART) Shares Gap Down Following Weak Earnings - Defense World
Integra LifeSciences (IART) Faces Adjusted Price Target Amid Rev - GuruFocus
Integra LifeSciences (IART) Faces Adjusted Price Target Amid Revenue Concerns | IART Stock News - GuruFocus
Wells Fargo Lowers Price Target for Integra Lifesciences (IART) - GuruFocus
JP Morgan Adjusts Price Target for Integra Lifesciences (IART) | IART Stock News - GuruFocus
Wells Fargo Lowers Price Target for Integra Lifesciences (IART) | IART Stock News - GuruFocus
Integra LifeSciences Holdings Corporation (NASDAQ:IART) Q1 2025 Earnings Call Transcript - Insider Monkey
Attention Long-Term Shareholders of Integra LifeSciences Holdings Corporation (NASDAQ: IART); Mercury Systems, Inc. (NASDAQ: MRCY); Monolithic Power Systems, Inc. (NASDAQ: MPWR); and Virtu Financial Inc. (NASDAQ: VIRT): Grabar Law Office is Inv - GlobeNewswire
Wells Fargo Adjusts Integra LifeSciences (IART) Price Target | I - GuruFocus
Raymond James Financial Inc. Makes New Investment in Integra LifeSciences Holdings Co. (NASDAQ:IART) - Defense World
Integra Lifesciences Holdings Corp (IART) Q1 2025 Earnings Call Highlights: Navigating ... - Yahoo Finance
Integra LifeSciences (IART) Reports Q1 2025 Results and Strategi - GuruFocus
Stock Hits Across The Board As Companies Adjust Expectations - Finimize
Integra Lifesciences Q1 2025 Earnings: Adjusted EPS of $0.41 Bea - GuruFocus
Integra LifeSciences (IART) Q1 Earnings: Misses EPS, Exceeds Rev - GuruFocus
Integra LifeSciences (IART) Reports Q1 2025 Results and Strategic Moves - GuruFocus
Integra: Q1 Earnings Snapshot - The Washington Post
Integra LifeSciences Q1 2025 Earnings Call Transcript - MarketBeat
Long-Term Shareholders Have Rights – If You Hold Akero - GlobeNewswire
Long-Term Shareholders Have Rights – If You Hold Akero Therapeutics, Inc. (NASDAQ: AKRO); Integra Lifesciences Holdings Corporation (NASDAQ: IART); Mercury Systems, Inc. (NASDAQ: MRCY); or Virtu Financial Inc. (NASDAQ: VIRT), Contact Grabar La - TradingView
Earnings call transcript: Integra LifeSciences misses Q1 2025 targets, stock plunges - Investing.com
Integra Lifesciences Holdings Corp reports results for the quarter ended March 31Earnings Summary - TradingView
Integra LifeSciences misses Q1 estimates, shares fall 4% - Investing.com
Integra LifeSciences Slashes FY25 Adj. EPS OutlookUpdate - Nasdaq
Integra Lifesciences Q1 2025 Earnings: Adjusted EPS of $0.41 Beats Estimates, Revenue Hits $382.7 Million - GuruFocus
Integra LifeSciences (IART) Q1 Earnings: Misses EPS, Exceeds Revenue Expectations - GuruFocus
Integra LifeSciences Reports First Quarter 2025 Financial Results - TradingView
Integra LifeSciences (IART) Reports Q1 Revenue Surpassing Expectations | IART Stock News - GuruFocus
Integra LifeSciences (NASDAQ:IART) Reports Q1 In Line With Expectations But Quarterly Revenue Guidance Significantly Misses Expectations - Yahoo Finance
Integra Lifesciences Holdings Corp (IART) Performance and Fundamentals Dashboard tells a completely different story - Sete News
Earnings To Watch: Integra Lifesciences Holdings Corp (IART) Rep - GuruFocus
Stock Performance Spotlight: Integra Lifesciences Holdings Corp (IART) Ends the Day at 16.44, Up by 0.31 - DWinneX
Is Integra Lifesciences Holdings Corp (IART) a good investment opportunity? - uspostnews.com
The Future of Integra Lifesciences Holdings Corp: Analyzing IART - investchronicle.com
An Analysis of Integra Lifesciences Holdings Corp (IART)’s Potential Price Growth - knoxdaily.com
Notice to Long-Term Shareholders of Integra Lifesciences Holdings Corporation (NASDAQ: IART); Methode Electronics, Inc. (NYSE: MEI); Monolithic Power Systems, Inc. (NASDAQ: MPWR); and Virtu Financial Inc. (NASDAQ: VIRT): Grabar Law Office Investig - GlobeNewswire
Analysts Set Integra LifeSciences Holdings Co. (NASDAQ:IART) Target Price at $22.71 - Defense World
Integra Lifesciences Holdings Corp (NASDAQ:IART) Price Forecast For The Next 12 Months Is Set At 86. - Marketing Sentinel
Notice to Long-Term Shareholders of Integra Lifesciences - GlobeNewswire
Integra Lifesciences Holdings Corp (IART) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - Sete News
IART Stock Sees Surge of Approximately 1.12% in Last Five Days - knoxdaily.com
Notice to Long-Term Shareholders of BioAge Labs, Inc. - GlobeNewswire
Post-Trade Analysis: Integra Lifesciences Holdings Corp (IART) Climbs 3.16, Closing at 15.67 - DWinneX
Integra LifeSciences stock hits 52-week low at $15.45 - Investing.com
Integra Lifesciences Holdings Corp Stock (IART) Financials Data
Revenue
Net Income
Cash Flow
EPS
Integra Lifesciences Holdings Corp Stock (IART) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Singh Harvinder | EVP & PRESIDENT, INTERNATIONAL |
Mar 10 '25 |
Option Exercise |
0.00 |
1,180 |
0 |
2,359 |
| Schwartz Eric | EVP, Chief Legal Officer & Sec |
Dec 03 '24 |
Sale |
24.59 |
4,070 |
100,102 |
59,511 |
1.26%
0.59%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):